Informationen:
Fehler:
ID
42098
Beschreibung
Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT02109653
Link
https://clinicaltrials.gov/show/NCT02109653
Stichworte
Versionen (2)
- 28.09.15 28.09.15 - Julian Varghese
- 09.04.21 09.04.21 - Ahmed Rafee, MD
Rechteinhaber
AR
Hochgeladen am
9. April 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-Small Cell Lung Cancer NCT02109653
Eligibility Non-Small Cell Lung Cancer NCT02109653
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-Small Cell Lung Cancer NCT02109653
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
v600e mutation
Item
presence of braf v600e mutation in tumor tissue
boolean
C3811884 (UMLS CUI [1])
stage iiib or iv nsclc
Item
histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc
boolean
C0278984 (UMLS CUI [1])
C0278987 (UMLS CUI [2])
C0278987 (UMLS CUI [2])
measurable lesion as defined by recist
Item
at least one measurable lesion as defined by recist v1.1
boolean
C0221198 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C1709926 (UMLS CUI [1,3])
C1513040 (UMLS CUI [1,2])
C1709926 (UMLS CUI [1,3])
systemic, anti-cancer treatment; advanced or metastatic nsclc
Item
patients must have progressed during or after at least one previous systemic, anti-cancer treatment for locally advanced or metastatic nsclc.
boolean
C1515119 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
eastern cooperative oncology group; performance status
Item
eastern cooperative oncology group (ecog)/world health organization (who) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
symptomatic central nervous system involvement; metastases; cns
Item
patients with symptomatic central nervous system (cns) metastases
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
leptomeningeal metastases
Item
history of leptomeningeal metastases
boolean
C1704231 (UMLS CUI [1])
prior therapy
Item
prior therapy with a braf inhibitor
boolean
C3838813 (UMLS CUI [1])
medication; protocol
Item
patients taking prohibited medication listed in the protocol
boolean
C0525058 (UMLS CUI [1])
malignant disease other than nsclc
Item
presence or history of a malignant disease other than nsclc that has been diagnosed and/or required therapy within the past 3 years.
boolean
C0006826 (UMLS CUI [1])
significant cardiovascular diseases
Item
impaired cardiovascular function or clinically significant cardiovascular diseases
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
pregnant or lactating women of childbearing potential
Item
pregnant or lactating women or woman of childbearing potential
boolean
C0549206 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
C3831118 (UMLS CUI [3])
C2828358 (UMLS CUI [2])
C3831118 (UMLS CUI [3])